Products derived from amniotic membranes and placental tissues have been used clinically in a wide range of applications. Consult your physician to determine if HRT products are right for your procedure.
HRT® placental tissue grafts are derived from donated tissues, which are collected from live, healthy, U.S.-based donors following successful C-section delivery.
Amniotic tissues are considered non-immunogenic, meaning there is little or no risk of response in the recipient, which can lead to graft rejection or fibrosis.
All HRT® donor and tissue screening is performed according to stringent safety standards, which meet or exceed all applicable industry requirements.